Kampanjeplan Dynavax Technologies Corporation
Avansert tidsplan
Enkel graf
Om selskapet Dynavax Technologies Corporation
Dynavax Technologies Corporation, биофармацевтическая компания, специализируется на разработке и коммерциализации новых вакцин в Соединенных Штатах. Компания продает HEPLISAV-B, вакцину против гепатита B для предотвращения инфекции, вызываемой всеми известными подтипами вируса гепатита B, в возрасте 18 лет и старше в Соединенных Штатах и Европе. Он также производит и продает CpG 1018, адъювант, используемый в HEPLISAV-B. Корпорация Dynavax Technologies заключила соглашение о сотрудничестве с Valneva Scotland Limited; соглашение с Serum Institute of India Pvt. Ltd . flere detaljerIPO date | 2004-02-19 |
---|---|
ISIN | US2681582019 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | https://www.dynavax.com |
Цена ао | 13.74 |
Prisendring per dag: | -0.3639% (13.74) |
---|---|
Prisendring per uke: | -4.93% (14.4) |
Prisendring per måned: | +9.96% (12.45) |
Prisendring over 3 måneder: | +5.63% (12.96) |
Prisendring over seks måneder: | +22.78% (11.15) |
Prisendring per år: | +13.61% (12.05) |
Prisendring over 3 år: | +22.67% (11.16) |
Prisendring over 5 år: | +220.61% (4.27) |
Prisendring over 10 år: | 0% (13.69) |
Prisendring siden begynnelsen av året: | +6.7% (12.83) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
Blackrock Inc. | 23 | 17.72 |
State Street Corporation | 11 | 8.11 |
Vanguard Group Inc | 9 | 7.18 |
Deep Track Capital, LP | 9 | 6.98 |
Federated Hermes, Inc. | 8 | 6.1 |
Chicago Capital, LLC | 6 | 4.31 |
Kynam Capital Management, LP | 4 | 3.24 |
Goldman Sachs Group Inc | 4 | 3.19 |
Dimensional Fund Advisors LP | 4 | 3.1 |
Geode Capital Management, LLC | 3 | 2.23 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Ryan Spencer | CEO & Director | 1.25M | 1978 (47 år) |
Mr. David F. Novack | President & COO | 925.6k | 1962 (63 år) |
Ms. Kelly MacDonald | Senior VP & CFO | 674.27k | 1984 (41 år) |
Mr. Justin Burgess | Chief Accounting Officer & Controller | N/A | |
Mr. Jeff P. Coon | Senior VP & Chief Human Resources Officer | N/A | 1963 (62 år) |
Mr. Donn Casale | Senior VP & Chief Commercial Officer | N/A | |
Mr. Paul Cox | VP of Investor Relations & Corporate Communications | N/A | |
Dr. Dong Yu | Senior Vice President of Vaccine Research | N/A | |
Dr. Robert Janssen M.D. | Chief Medical Officer and Senior VP of Clinical Development, Medical & Regulatory Affairs | 1954 (71 år) | |
Mr. John L. Slebir | Senior VP & General Counsel | 1966 (59 år) |
Adresse: United States, EmeryVille, CA , 2100 Powell Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.dynavax.com
Nettsted: https://www.dynavax.com